SER

Conviction 73HealthcareScan · Mon, Aug 10, 2026

SER$2.71+12.92%

ResistanceSupportVol 14Insider buy

Vol MA14 44.15K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Serina Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.serinatherapeutics.com ↗

Price2.71

Change+12.92%

Gap+0.83%

Rel volume6.25×

Avg volume40.76K

Avg $ vol92.73K

SMA 202.15

SMA 502.01

SMA 2002.46

Price vs 50+34.87%

Price vs 200+10.30%

MA stackmixed

50/200 cross—

Supertrendup · 1.99

RSI (14)75

MACD hist0.05

MACD crossbull · 3d

Stoch %K / %D100 / 97

ADX (14)22

+DI / −DI31 / 9

RSI divergence—

MACD divergence—

ATR %+6.42%

ADR %7.32%

52w high5.65

52w low1.28

From 52w high-52.04%

Above 52w low+111.72%

New 52w highNo

SqueezeFired

Bollinger width31.41%

%B1.34

Donchian pos100.00%

Donchian high2.71

Donchian low1.93

AVWAP (52w high)2.79

vs AVWAP high-2.80%

AVWAP (52w low)2.43

vs AVWAP low+11.39%

OBV trendUp

Chaikin MF (20)0.23

Today vs 20d6.25×

Avg vol (14d)44.15K

Avg vol (20d)40.76K

Avg $ vol (20d)92.73K

Market cap40.64M

RS 3m (vs SPY)+26.90%

RS 6m (vs SPY)-16.95%

RS line new highYes

Trend template4/8

Technical rank84.2

1 week+31.55%

1 month+26.64%

3 months+54.86%

6 months+14.35%

1 year-50.28%

YTD+30.41%

P/E-2.12

P/B-1098.47

P/S312.64

P/FCF-2.26

EPS-1.91

Div yield—

ROE—

ROA-70.27%

Debt/Eq—

Current4.18

EV/EBITDA-1.14

Gross margin78.46%

Net margin—

Rev growth132.14%

EPS growth-72.17%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value27.27M

Revenue0

Net income-6.9M

Gross profit34K

Free cash flow-18.01M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out15M

Employees16

ListedWed, Mar 27, 2024

Free float2.89M

Float %26.8%

Short interest284.55K

Days to cover5.2d

Short volume49.8%

Squeeze score66 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction73 / 100

Pattern quality—

Tech rank84.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.28

Support1.74

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SER

All disclosures →

No recent disclosed trades by Congress in SER. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SER · 8 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Brannan Stephen K. Director · Common Stock · 2026-07-07	Buy	1K	$2K	2026-07-07	2026-07-09
Bailey Gregory Director · Common Stock · 2026-06-17	Convert	1.77M	$4.0M	2026-06-17	2026-06-22
Bailey Gregory Director · Common Stock · 2026-06-17	Convert	6.67M	$15M	2026-06-17	2026-06-22
Marshall Richard Peter Director · Stock Option (right to buy) · 2026-06-17	Grant	15.25K	—	2026-06-17	2026-06-22
Venkatesan Jay Director · Series A Convertible Preferred Stock · 2026-06-17	Convert	96.53K	$217K	2026-06-17	2026-06-22
Bailey Gregory Director · Stock Option (right to buy) · 2026-06-17	Grant	15.25K	—	2026-06-17	2026-06-22
Bailey Gregory Director · Redeemable Warrants · 2026-06-17	Grant	3.33M	—	2026-06-17	2026-06-22
Venkatesan Jay Director · Common Stock · 2026-06-17	Convert	224.15K	$504K	2026-06-17	2026-06-22
Venkatesan Jay Director · Stock Option (right to buy) · 2026-06-17	Grant	15.25K	—	2026-06-17	2026-06-22
Bailey Gregory Director · Series A Convertible Preferred Stock · 2026-06-17	Convert	762.55K	$1.7M	2026-06-17	2026-06-22

SEC filings

EDGAR filings in SER · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.